Purchase Order 75N92018P00166
- Not listed
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a Firm Fixed Price Purchase Order to Cerba Research USA, Inc., a for-profit organization, to conduct research and assay serum biomarkers. The $66,334.00 contract has a completion date of June 30, 2022. Cerba Research USA, Inc. will perform the work at its laboratory in New Hyde Park, New York and has not indicated any subcontractors. Cerba Research USA, Inc. holds additional...
- This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute to Cerba Research USA Inc., a for-profit organization that provides clinical trial and laboratory services to support biomedical research. The $108,028.00 fixed-price purchase order is for Cerba Research to provide clinical laboratory testing and associated data management services, to be performed at the company's New York laboratory. No subcontractors...
- This firm fixed-price purchase order was awarded by the National Human Genome Research Institute, a civilian agency within the U.S. Department of Health and Human Services, to Cerba Research USA, Inc. for $126,198.00. The contract is for the provision of a clinical chemistry panel to support biomedical research in West African populations. The period of performance runs through August 17, 2025. This award is not designated as a set-aside contract. Cerba Research USA, Inc. is a for-profit...
- This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Cerba Research USA, Inc., a for-profit organization. The $529,892 award will fund clinical central laboratory services in support of three NIAID clinical protocols related to infectious diseases. This work will be performed at Cerba Research's facility in New Hyde Park, New York. The award is not associated...
- This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Cerba Research USA, Inc. for SARS-CoV-2 testing support. The total award value is $1,382,498.14, with a total ceiling of $1,615,094.14. The period of performance runs through December 31, 2023. This award is not associated with a larger contract vehicle, and no set-aside designation was used. Cerba...
- This firm-fixed-price purchase order contract was awarded to CDI Laboratories Inc., a small disadvantaged business, to provide its proprietary HUPROT V4.0 ARRAY protein microarray product and related antibody profiling and analysis services to the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The $121,379.50 contract supports biomedical research efforts, particularly in the areas of infectious diseases, heart/lung disorders, aging, and...
- This is a federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), a civilian agency within the U.S. Department of Health and Human Services. The contract was awarded to USA Scientific, Inc., a foreign-owned, for-profit manufacturer of laboratory equipment, supplies, and scientific instruments. The contract is for the purchase of general lab supplies to perform cell culture, with a firm-fixed-price ceiling value of...
- The Department of Health and Human Services' National Institutes of Health Clinical Center awarded an approximately $18,351 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for products and services to be delivered through August 2024. As the prime contractor, BD Biosciences will provide biological testing materials to support biomedical research activities at the NIH Clinical Center, a hospital dedicated to clinical research. No...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the Department of Health and Human Services (HHS), to Global Life Sciences Solutions USA LLC. The $517,728.16 firm fixed-price purchase order is for the delivery of scientific equipment, biological materials, and associated services to support the agency's biomedical research programs. This award is part of a larger $1.176 billion cooperative agreement with Global Life Sciences...
- <p>The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $249,648.00 firm fixed price purchase order to Medical Neurogenetics, LLC, a for-profit organization, for clinical genetic testing services. The contract has a completion date of November 2, 2023 and does not have a set-aside designation. The place of performance is Bethesda, Maryland.</p>
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute awarded a $112,198.00 firm fixed price purchase order to Cerba Research USA Inc., a for-profit organization, to procure the services of BARC to assay serum biomarkers. The work is to be performed in Bethesda, Maryland and there are no set-aside designations or subcontractors indicated. Cerba Research USA Inc. is a clinical trial and laboratory services provider that maintains CLIA certification and has received prior federal contracts from NIH agencies including the National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, and National Cancer Institute for related services. Additionally, the company holds a $5 million single-award indefinite delivery contract from the National Institute of Allergy and Infectious Diseases for clinical central laboratory services to support the Institute's vaccine and therapeutic clinical trials program.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
To Procure the services of BARC to assay serum biomarkers. | 75N92018Q0192 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 7/2/18, 8:12 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($2k) | 12/8/22 | |
| Not listed | Not listed | $114.7k | 7/31/18 |